within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FA08_Troleandomycin;

model Troleandomycin
  extends Pharmacolibrary.Drugs.ATC.J.J01FA08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01FA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Troleandomycin is a macrolide antibiotic, structurally related to erythromycin. It was formerly used for the treatment of infections caused by susceptible bacteria and also investigated for use in asthma and for steroid-sparing effects. Troleandomycin is currently not widely used in clinical practice and is not approved in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult, as there is no published pharmacokinetic study available with detailed compartmental analysis.</p><h4>References</h4><ol><li><p>Wang, JS, Wang, W, Xie, HG, Huang, SL, &amp; Zhou, HH (1997). Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A. <i>British journal of clinical pharmacology</i> 44(2) 195–198. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.1997.00649.x\">10.1046/j.1365-2125.1997.00649.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9278210/\">https://pubmed.ncbi.nlm.nih.gov/9278210</a></p></li><li><p>Rodvold, KA (1999). Clinical pharmacokinetics of clarithromycin. <i>Clinical pharmacokinetics</i> 37(5) 385–398. DOI:<a href=\"https://doi.org/10.2165/00003088-199937050-00003\">10.2165/00003088-199937050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10589373/\">https://pubmed.ncbi.nlm.nih.gov/10589373</a></p></li><li><p>Periti, P, Mazzei, T, Mini, E, &amp; Novelli, A (1992). Pharmacokinetic drug interactions of macrolides. <i>Clinical pharmacokinetics</i> 23(2) 106–131. DOI:<a href=\"https://doi.org/10.2165/00003088-199223020-00004\">10.2165/00003088-199223020-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1511528/\">https://pubmed.ncbi.nlm.nih.gov/1511528</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Troleandomycin;
